Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSMIP 004 is an SKP2 (S-phase kinase-associated protein 2) inhibitor. Upregulates p27 and activates the unfolded protein response (UPR) in LNCaP prostate cancer cells overexpressing SKP2. Also induces oxidative stress. Induces proteasomal degradation of cyclin D1 and acts as CDK2 inhibitor. Arrests cell cycle in G1 phase and induces apoptosis in prostate cancer cells, but not normal cells in vitro. Inhibits growth of breast and prostate cancer xenografts in mice. Also induces autophagy and reduces replication of MERS-CoV in VeroB4 cells.
SMIP 004 is also offered as part of the Tocriscreen Epigenetics Library. 了解 Tocris 化合物库的更多信息。
分子量 | 205.3 |
公式 | C13H19NO |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 143360-00-3 |
PubChem ID | 2747581 |
InChI Key | ZFVMECVBUGMWIX-UHFFFAOYSA-N |
Smiles | CCCCC1=CC(C)=C(NC(C)=O)C=C1 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
DMSO | 20.53 | 100 |
以下数据基于产品分子量 205.3。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 4.87 mL | 24.35 mL | 48.71 mL |
5 mM | 0.97 mL | 4.87 mL | 9.74 mL |
10 mM | 0.49 mL | 2.44 mL | 4.87 mL |
50 mM | 0.1 mL | 0.49 mL | 0.97 mL |
参考文献是支持产品生物活性的出版物。
Rico-Bautista et al (2010) Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells. BMC Biol. 8 153 PMID: 21182779
Rico-Bautista et al (2013) Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling. Oncotarget 4 1212 PMID: 23902736
Gassen et al (2019) SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat.Commun. 10 5770 PMID: 31852899
If you know of a relevant reference for SMIP 004, please let us know.
关键词: SMIP 004, SMIP 004 supplier, SMIP004, S-phase, kinase-associated, protein, 2, SKP2, E3, ligase, inhibitors, inhibits, p27, upregulates, MERS-CoV, unfolded, response, UPR, activates, activators, CDK2, CKI, cyclin, dependent, kinase, ubiquitin, Ubiquitin, Ligases, Coronavirus, Other, ER, stress/UPR, CDK1, Subfamily, 7192, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 SMIP 004 的引用文献。 您是否知道使用了 Tocris SMIP 004 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review SMIP 004 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia